YUSIMRY Solutions Copay Savings Program
Meitheal Pharmaceuticals, Inc. · Yusimry
Through your pharmacy
Patient pays: as little as $0 per dose
commercial insurance
Patient assistance
Tell us your insurance and household details. We’ll show you every Yusimry assistance program you may qualify for - the real manufacturer and foundation programs, not a discount card - with sources and a direct link to apply. About a minute, no login.
Every Yusimry program linked to its official source, with the date we checked it - rules, income limits, and application links included.
Yusimry (adalimumab-aqvh) is a tnf-alpha inhibitor (biosimilar to humira) made by Meitheal Pharmaceuticals (formerly Coherus BioSciences). It is commonly prescribed for: Rheumatoid arthritis, Juvenile idiopathic arthritis, Psoriatic arthritis, Ankylosing spondylitis, Crohn's disease, Ulcerative colitis, Plaque psoriasis, Hidradenitis suppurativa. Without financial assistance, Yusimry typically costs around $995 per month.
At a glance
As of July 2026, mendmeds tracks 2 Yusimry assistance programs, 1 of which is open to patients with no insurance.
Tell us five things. We’ll do the rest.
Reference
This is the full list before we filter by your situation. Use the calculator above to see only the ones you may qualify for.
Meitheal Pharmaceuticals, Inc. · Yusimry
Through your pharmacy
Patient pays: as little as $0 per dose
commercial insurance
Mark Cuban Cost Plus Drug Company (MCCPDC) · Yusimry
Buy directly from the maker
Patient pays: $569.27 per carton (two 40 mg/0.8 mL pen-injectors) plus dispensing and shipping fees
uninsured · commercial insurance · self-pay
We couldn’t confirm the current terms - call the program to verify.
Common questions
Related drugs